BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26553712)

  • 21. Developing a cardiology-oncology clinical practice guideline.
    Lindenfeld J; Kelly PA
    Prog Cardiovasc Dis; 2010; 53(2):173-9. PubMed ID: 20728705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardio-oncology: a tremendous opportunity to improve patient care.
    Lenihan DJ; Westcott G
    Future Oncol; 2015; 11(14):2007-10. PubMed ID: 26198827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart disease in cancer patients: a burgeoning field where optimizing patient care is requiring interdisciplinary collaborations.
    Lenihan DJ; Sawyer DB
    Heart Fail Clin; 2011 Jul; 7(3):xxi-xxiii. PubMed ID: 21749881
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiotoxicity of targeted agents in oncology: a medical oncology perspective.
    Wong DJ; Hurvitz SA
    Oncology (Williston Park); 2014 Jun; 28(6):490-2. PubMed ID: 25134322
    [No Abstract]   [Full Text] [Related]  

  • 25. Patients undergoing cancer treatments need monitoring to prevent heart injuries.
    Health News; 2004 Nov; 10(11):9. PubMed ID: 15655855
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac toxicity from systemic cancer therapy: a comprehensive review.
    Curigliano G; Mayer EL; Burstein HJ; Winer EP; Goldhirsch A
    Prog Cardiovasc Dis; 2010; 53(2):94-104. PubMed ID: 20728696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical vignettes: integrated care of cancer patients by oncologists and cardiologists.
    Hofstatter E; Saadati H; Russell K; Russell R
    Curr Cardiol Rev; 2011 Nov; 7(4):258-61. PubMed ID: 22758627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Points to Remember: Practical Pearls in Onco-Cardiology.
    Preti HA
    Methodist Debakey Cardiovasc J; 2015; 11(4):254. PubMed ID: 27057298
    [No Abstract]   [Full Text] [Related]  

  • 29. Early detection of treatment induced cardiac toxicity - can we do better?
    Lombard JM; Paterson R
    Asia Pac J Clin Oncol; 2013 Jun; 9(2):97-8. PubMed ID: 23682667
    [No Abstract]   [Full Text] [Related]  

  • 30. Arterial thrombotic events and acute coronary syndromes with cancer drugs: are growth factors the missed link?: what both cardiologist and oncologist should know about novel angiogenesis inhibitors.
    Conti E; Romiti A; Musumeci MB; Passerini J; Zezza L; Mastromarino V; D'Antonio C; Marchetti P; Paneni F; Autore C; Volpe M
    Int J Cardiol; 2013 Sep; 167(6):2421-9. PubMed ID: 23414744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulator of G-protein signaling 6 (RGS6) in cardiology and oncology.
    Patanè S
    Int J Cardiol; 2015; 187():99-102. PubMed ID: 25828322
    [No Abstract]   [Full Text] [Related]  

  • 32. CardioPulse: cardiac imaging of adult cancer patients on chemotherapy.
    Galderisi M; Lancellotti P
    Eur Heart J; 2015 Apr; 36(15):889-90. PubMed ID: 26052605
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardio-oncology and echocardiography-partners in improving patient care.
    Wiegers SE
    J Am Soc Echocardiogr; 2015 Nov; 28(11):A15. PubMed ID: 26542336
    [No Abstract]   [Full Text] [Related]  

  • 34. Managing cardiac risk factors in oncology clinical trials.
    Tsimberidou AM; Minotti G; Cardinale D
    Tex Heart Inst J; 2011; 38(3):266-7. PubMed ID: 21720468
    [No Abstract]   [Full Text] [Related]  

  • 35. The many challenges of veterinary oncology.
    Kidd C
    Can Vet J; 2008 Nov; 49(11):1132-5. PubMed ID: 19183739
    [No Abstract]   [Full Text] [Related]  

  • 36. Cancer care expands to include genetic testing.
    Johns Hopkins Med Lett Health After 50; 2009 Jan; 20(11):4-5. PubMed ID: 19408409
    [No Abstract]   [Full Text] [Related]  

  • 37. [2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines].
    Zamorano JL; Lancellotti P; Muñoz DR; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GY; Lyon AR; Fernandez TL; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM
    Kardiol Pol; 2016; 74(11):1193-1233. PubMed ID: 27910076
    [No Abstract]   [Full Text] [Related]  

  • 38. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.
    Ewer MS; Lippman SM
    J Clin Oncol; 2005 May; 23(13):2900-2. PubMed ID: 15860848
    [No Abstract]   [Full Text] [Related]  

  • 39. [Oncological intensive care: 2011 year's review].
    Sculier JP; Berghmans T; Meert AP
    Rev Med Brux; 2012; 33(6):540-4. PubMed ID: 23373125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac disease in cancer patients: an overview.
    Mann DL; Krone RJ
    Prog Cardiovasc Dis; 2010; 53(2):80-7. PubMed ID: 20728694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.